PB2122 VELCADITO. A PHASE II TRIAL WITH LOW DOSES OF BORTEZOMIB PLUS MELPHALAN AND PREDNISONE FOR ELDERLY PATIENTS (>75Y) WITH NEWLY DIAGNOSED MULTIPLE MYELOMA
Persona, E. Pérez, Ormategui, I. Oiartzabal, Angulo, R. Diez, Cilaurren, A. Unamunzaga, Salinas, I. M. Parra, Lopez, A. Santamaría, Palomares, L. Cuevas, Robles de Castro, D., Miguel Sánchez, C., Jalón, M. Gabilondo, Herrero, C. Pisón, Navarro, G. A. Mendez, Vega González de Viñaspre, A., Guinea de Castro, J. M.
Published in HemaSphere (01.06.2019)
Published in HemaSphere (01.06.2019)
Get full text
Journal Article